[1]
Tandia, M. et al. 2020. Bevacizumab and Sorafenib Modulate P-Glycoprotein Function In Vitro and Bevacizumab Increases In Vivo Sorafenib Plasma Concentrations in Mice. International Journal of Innovative Research in Medical Science. 5, 08 (Aug. 2020), 261–267. DOI:https://doi.org/10.23958/ijirms/vol05-i08/396.